BMC Neurology (Nov 2024)

Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients

  • Edoardo Nicolò Aiello,
  • Federica Solca,
  • Silvia Torre,
  • Beatrice Curti,
  • Giulia De Luca,
  • Ruggero Bonetti,
  • Francesco Scheveger,
  • Eleonora Colombo,
  • Alessio Maranzano,
  • Marco Olivero,
  • Claudia Morelli,
  • Alberto Doretti,
  • Luca Maderna,
  • Federico Verde,
  • Roberta Ferrucci,
  • Sergio Barbieri,
  • Fabiana Ruggiero,
  • Denise Mellace,
  • Angelica Marfoli,
  • Angelica De Sandi,
  • Alberto Priori,
  • Gabriella Pravettoni,
  • Vincenzo Silani,
  • Nicola Ticozzi,
  • Andrea Ciammola,
  • Barbara Poletti

DOI
https://doi.org/10.1186/s12883-024-03920-9
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background . The present study aimed at deriving regression-based reliable change indices (RCIs) for the Montreal Cognitive Assessment (MoCA) in an Italian cohort of non-demented Parkinson’s disease (PD) patients. Methods N = 33 consecutive, non-demented PD patients were followed-up at a 5-to-8-month interval (M = 6.6; SD = 0.6) with the MoCA. Practice effects and test-retest reliability were assessed via dependent-sample t-tests and intra-class correlation (ICC) coefficients, respectively. RCIs were derived separately for raw and demographically adjusted MoCA scores according to a standardized regression-based approach by accounting for both baseline confounders (i.e., demographics, disease duration and Unified Parkinson’s Disease Rating Scale scores) and retest interval. Results No practice effects were found (t(32) = 0.29; p = .778), with acceptable test-retest reliability being detected (ICC = 0.67). MoCA scores at T0 proved to be the only significant predictor of T1 MoCA performances within both the model addressing raw scores and that addressing adjusted scores (ps < 0.001). Conclusions The present study provides Italian practitioners and researchers with regression-based RCIs for the MoCA in non-demented PD patients, which can be reliably adopted for retest interval ≥ 5 and ≤ 8 months without encountering any practice effect.

Keywords